Skip to main content
$160.68 $3.48 (2.2%)

04:00 PM EST on 01/27/23

Alexandria Real Estate Equities, Inc. (NYSE:ARE)

CAPS Rating: 4 out of 5

The Company is engaged principally in the ownership, operation, management, selective redevelopment, development and acquisition of properties for the life sciences industry.

Current Price $160.68 Mkt Cap $25.8B
Open $157.14 P/E Ratio 47.72
Prev. Close $160.68 Div. (Yield) $4.84 (3.1%)
Daily Range $156.62 - $160.95 Volume 866,483
52-Wk Range $126.74 - $206.85 Avg. Daily Vol. 772,439

Caps

How do you think NYSE:ARE will perform against the market?

Add Stock to CAPS Watchlist

All Players

105 Outperform
53 Underperform
 

All-Star Players

21 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:ARE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mrbill6 (58.77)
Submitted October 15, 2022

Opportunity: These 5 Dividend Growth Stocks Are Down Bigby Jason Fieber, Mr. Free at 33 • October 15, 2022“Be greedy when others are fearful.”

Ewok82 (27.44)
Submitted May 25, 2009

Expensive property in a niche market for life science research seems to be a bit speculative in this market, especially given that some of these properties are in cities like SF, where prices continue to fall as taxes continue to rise.

Recent Community Commentary

Read the most recent pitches from players about ARE.

Recs

1
Member Avatar mrbill6 (58.77) Submitted: 10/15/2022 11:30:20 AM : Outperform Start Price: $133.90 NYSE:ARE Score: +8.18

Opportunity: These 5 Dividend Growth Stocks Are Down Big
by Jason Fieber, Mr. Free at 33 • October 15, 2022
“Be greedy when others are fearful.”

Recs

1
Member Avatar SanFranFan (< 20) Submitted: 6/24/2022 2:03:00 AM : Outperform Start Price: $136.83 NYSE:ARE Score: +10.71

I've owned ARE since 2008 and just added to my position. Their life sciences focus means that they likely will be less impacted by the move to telework, and they've just been a solid performer.

Recs

1
Member Avatar BrentonKJ (< 20) Submitted: 6/23/2022 12:32:53 PM : Outperform Start Price: $127.10 NYSE:ARE Score: +14.95

Growth reit in healthcare

Leaderboard

Find the members with the highest scoring picks in ARE.

Score Leader

SSPX3

SSPX3 (45.52) Score: +311.39

The Score Leader is the player with the highest score across all their picks in ARE.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SSPX3 45.52 5/14/2009 Outperform NS $20.74 +675.32% +363.93% +311.39 0 Comment
czarl 72.86 5/27/2009 Outperform NS $23.64 +580.11% +350.17% +229.94 0 Comment
TraderJFH 96.16 7/22/2009 Outperform 1Y $24.90 +545.89% +327.55% +218.34 0 Comment
crabbucket1 < 20 5/4/2009 Outperform 3M $23.63 +580.48% +364.85% +215.63 1 Comment
mitchiemono 75.09 4/27/2009 4/24/2010 Outperform 3Y $24.19 +564.86% +380.43% +184.43 0 Comment
NSHanlon 52.20 4/27/2009 Outperform 3Y $24.19 +564.86% +380.43% +184.43 0 Comment
SSPXXX 69.82 6/8/2009 Outperform 5Y $26.96 +496.55% +338.62% +157.93 0 Comment
Lance03 40.44 3/9/2009 Outperform NS $21.16 +659.82% +510.08% +149.74 0 Comment
TMFMattyA 99.90 9/17/2013 Outperform 5Y $47.96 +235.29% +138.18% +97.11 1 Comment
mamabourne 97.32 8/7/2008 Underperform 3M $68.59 +134.45% +227.70% +93.25 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ARE.